-Network: (00010 - Document - Document and Entity Information)

-Document and Entity Information {ID1}

-Document Information {ID2}

Document type {ID3}

Document period end date {ID4}

Amendment flag {ID5}

Amendment description {ID6}

-Entity Information {ID7}

Entity registrant name {ID8}

Entity central index key {ID9}

Entity current reporting status {ID10}

Entity voluntary filers {ID11}

Current fiscal year end date {ID12}

Entity filer category {ID13}

Entity well known seasoned issuer {ID14}

Entity common stock shares outstanding {ID15}

Entity public float {ID16}

-Network: (00020 - Statement - Consolidated Statements of Income (unaudited))

-Consolidated Statements of Income {ID17}

-Net revenue: {ID18}

Dialysis Care Revenue {ID19}

Dialysis Products Revenue {ID20}

Net revenue {ID21}

-Costs of revenue: {ID22}

Dialysis Care Cost of Revenue {ID23}

Dialysis Products Cost of Revenue {ID24}

Cost of revenues {ID25}

Gross profit {ID26}

-Operating expenses: {ID27}

Selling, general and administrative {ID28}

Research and development {ID29}

Operating income {ID30}

-Other (income) expense: {ID31}

Interest income {ID32}

Interest expense {ID33}

Income before income taxes {ID34}

Income tax expense {ID35}

-Net Income {ID36}

Less: Net Income attributable to Noncontrolling interest {ID37}

Net Income attributable to the Company {ID38}

Basic income per ordinary share {ID39}

Fully diluted income per ordinary share {ID40}

-Network: (00030 - Statement - Consolidated Statements of Comprehensive Income (unaudited))

-Consolidated Statements of Comprehensive Income {ID41}

-Net Income {ID42}

Gain (loss) related to cash flow hedges {ID43}

Actuarial gains on defined benefit pension plans {ID44}

Foreign currency translation {ID45}

Income tax (expense) benefit related to components of other comprehensive income {ID46}

Other comprehensive income, net of tax {ID47}

-Total Comprehensive income {ID48}

Comprehensive income attributable to noncontrolling interest {ID49}

Comprehensive income attributable to the Company {ID50}

-Network: (00040 - Statement - Consolidated Balance Sheets (unaudited))

-Consolidated Balance Sheets {ID51}

-Assets: {ID52}

-Current assets: {ID53}

Cash and cash equivalents {ID54}

Trade accounts receivable, less allowance for doubtful accounts of $264,684 in 2009 and $262,836 in 2008 {ID55}

Accounts receivable from related parties {ID56}

Inventories {ID57}

Prepaid expenses and other current assets {ID58}

Deferred tax asset, current {ID59}

Total current assets {ID60}

Property, plant and equipment, net {ID61}

Intangible assets {ID62}

Goodwill {ID63}

Deferred tax asset, non-current {ID64}

Other assets {ID65}

Assets {ID66}

-Liabilities and shareholders' equity {ID67}

-Current liabilities: {ID68}

Accounts payable {ID69}

Accounts payable to related parties {ID70}

Accrued expenses and other current liabilities {ID71}

Short-term borrowings {ID72}

Short-term borrowings from related parties {ID73}

Current portion of long-term debt and capital lease obligations {ID74}

Income tax payable, current {ID75}

Deferred tax liability, current {ID76}

Total current liabilities {ID77}

Long-term debt and capital lease obligations, less current portion {ID78}

Other liabilities {ID79}

Pension liabilities {ID80}

Income tax payable, non-current {ID81}

Deferred tax liability, non-current {ID82}

Company-obligated mandatorily redeemable preferred securities of subsidiary Fresenius Medical Care Capital Trusts holding solely Company-guaranteed debentures of subsidiaries {ID83}

Total liabilities {ID84}

-Company shareholders' equity: {ID85}

Preferred stock, no par value, 1.00 Euro nominal value, 12,356,880 shares authorized, 3,854,182 issued and outstanding {ID86}

Common stock, no par value, 1.00 Euro nominal value, 373,436,220 shares authorized, 294,365,648 issued and outstanding {ID87}

Common stock subscribed {ID88}

Additional paid-in capital {ID89}

Retained earnings {ID90}

Accumulated other comprehensive (loss) {ID91}

Total Company shareholders' equity {ID92}

Noncontrolling interest {ID93}

Total equity {ID94}

Total liabilities and equity {ID95}

-Network: (00045 - Statement - Consolidated Balance Sheets (unaudited) (Parentheticals))

-Consolidated Balance Sheets (Parentheticals) {ID96}

Trade accounts receivable allowance for doubtful accounts {ID97}

Preferred stock no par value (in Euros) {ID98}

Preferred stock authorized {ID99}

Preferred stock issued {ID100}

Preferred stock outstanding {ID101}

Common stock no par value (in Euros) {ID102}

Common stock authorized {ID103}

Common stock issued {ID104}

Common stock outstanding {ID105}

-Network: (00050 - Statement - Consolidated Statements of Cash Flows (unaudited))

-Consolidated Statements of Cash Flows {ID106}

-Operating Activities: {ID107}

Net Income {ID108}

-Adjustments to reconcile net income to net cash provided by operating activities: {ID109}

Depreciation and amortization {ID110}

Change in noncontrolling interest {ID111}

Change in deferred taxes, net {ID112}

(Gain) on sale of investments {ID113}

Loss on sale of fixed assets {ID114}

Stock Option Compensation Expense {ID115}

-Changes in assets and liabilities, net of amounts from businesses acquired: {ID116}

Trade accounts receivable, net {ID117}

Inventories, net {ID118}

Prepaid expenses, other current and non-current assets {ID119}

Accounts receivable, related parties {ID120}

Accounts payable, related parties {ID121}

Accounts payable, accrued expenses and other current and non-current liabilities {ID122}

Income tax payable {ID123}

Net cash provided by operating activities {ID124}

-Investing Activities: {ID125}

Purchases of property, plant and equipment {ID126}

Proceeds from sale of property, plant and equipment {ID127}

Acquisitions and investments, net of cash acquired, and net purchases of intangible assets {ID128}

Proceeds from divestitures {ID129}

Net cash used in investing activities {ID130}

-Financing Activities: {ID131}

Proceeds from short-term borrowings and other financial liabilities {ID132}

Repayments of short-term borrowings and other financial liabilities {ID133}

Proceeds from short-term borrowings from related parties {ID134}

Repayments of short-term borrowings from related parties {ID135}

Proceeds from long-term debt and capital lease obligations {ID136}

Repayments of long-term debt and capital lease obligations {ID137}

Redemption of trust preferred securities {ID138}

Increase of accounts receivable securitization program {ID139}

Proceeds from exercise of stock options {ID140}

Payment of Dividends {ID141}

Distributions to noncontrolling interest {ID142}

Contributions from noncontrolling interest {ID143}

Net cash used in financing activities {ID144}

Effect of exchange rate changes on cash and cash equivalents {ID145}

-Cash and Cash Equivalents: {ID146}

Net (decrease) in cash and cash equivalents {ID147}

Cash and cash equivalents at beginning of period {ID148}

Cash and cash equivalents at end of period {ID149}

-Network: (00060 - Statement - Consolidated Statements of Shareholders' Equity (unaudited))

-Consolidated Statements of Shareholders' Equity {ID150}

-Statement table {ID151}

-Statements of shareholders' equity by components {ID152}

-Total equity {ID153}

-Total Company shareholders' equity [Member] {ID154}

Preferred Stock [Member] {ID155}

Preferred Stock, No par value [Member] {ID156}

Preferred Stock, Subscribed [Member] {ID157}

Common Stock [Member] {ID158}

Common Stock, No par value [Member] {ID159}

Common Stock, Subscribed [Member] {ID160}

Additional paid in capital [Member] {ID161}

Retained earnings [Member] {ID162}

Accumulated other comprehensive income (loss) [Member] {ID163}

Noncontrolling interest [Member] {ID164}

-Statement [Line Items] {ID165}

Shareholders equity {ID166}

Shares issued {ID167}

-Proceeds from exercise of options and related tax effects {ID168}

Shares from exercise of options and related tax effects {ID169}

Compensation expense related to stock options {ID170}

Dividends paid {ID171}

Purchase (sale) of noncontrolling interest {ID172}

Cash contributions from noncontrolling interest {ID173}

Tax liability to be paid by noncontrolling interest {ID174}

-Comprehensive income (loss) {ID175}

Net Income {ID176}

Other comprehensive income (loss) {ID177}

Total Comprehensive income {ID178}

Shareholders equity {ID179}

Shares issued {ID180}

-Network: (00070 - Disclosure - Notes to Consolidated Financial Statements (unaudited))

-Note to Consolidated Financial Statements (unaudited) {ID181}

Shareholders' Equity {ID182}

-Network: (00100 - Disclosure - The Company and Basis of Presentation)

-Note to Consolidated Financial Statements (unaudited) {ID183}

The Company and Basis of Presentation {ID184}

-Network: (00200 - Disclosure - Related Party Transactions)

-Note to Consolidated Financial Statements (unaudited) {ID185}

Related Party Transactions {ID186}

-Network: (00300- Disclosure - Inventories)

-Note to Consolidated Financial Statements (unaudited) {ID187}

Inventories Note {ID188}

-Network: (00400 - Disclosure - Short-Term Borrowings and Short-Term Borrowings from Related Parties)

-Note to Consolidated Financial Statements (unaudited) {ID189}

Short-Term Borrowings and Short-Term Borrowings from Related Parties {ID190}

-Network: (00500 - Disclosure - Long-term Debt and Capital Lease Obligations)

-Note to Consolidated Financial Statements (unaudited) {ID191}

Long-term Debt and Capital Lease Obligations {ID192}

-Network: (00600 - Disclosure - Earnings Per Share)

-Note to Consolidated Financial Statements (unaudited) {ID193}

Earnings Per Share {ID194}

-Network: (00700 - Disclosure - Employee Benefit Plans)

-Note to Consolidated Financial Statements (unaudited) {ID195}

Employee Benefit Plans {ID196}

-Network: (00800 - Disclosure - Commitments and Contingencies)

-Note to Consolidated Financial Statements (unaudited) {ID197}

Commitments and Contingencies {ID198}

-Network: (00900 - Disclosure - Financial Instruments)

-Note to Consolidated Financial Statements (unaudited) {ID199}

Financial Instruments {ID200}

-Network: (01000 - Disclosure - Business Segment Information)

-Note to Consolidated Financial Statements (unaudited) {ID201}

Business Segment Information {ID202}

-Network: (01100 - Disclosure - Supplementary Cash Flow Information)

-Note to Consolidated Financial Statements (unaudited) {ID203}

Supplementary Cash Flow Information {ID204}

-Network: (01200 - Disclosure - Supplemental Condensed Combining Information)

-Note to Consolidated Financial Statements (unaudited) {ID205}

Supplemental Condensed Combining Information {ID206}

FRESENIUS MEDICAL CARE AG & Co. KGaA XBRL Taxonomy Presentation Networks